上實發展(600748.SH):子公司擬掛牌轉讓紹興上投100%股權及相應債權 掛牌底價為3.2億元
格隆匯11月19日丨上實發展(600748.SH)公佈,公司下屬全資子公司上海上投控股有限公司(“上投控股”)擬通過上海聯合產權交易所公開轉讓其所持有的紹興上投置業發展有限公司(“紹興上投”)100%股權及相應債權,本次交易起始掛牌價為人民幣3.2億元。
經測算,假設以掛牌價成交,預計本次交易所產生的淨利潤約為人民幣1.3-1.4億元之間,約佔公司上年度經審計歸屬於上市公司股東淨利潤的15.89%-17.11%,屬於公司董事會審議權限範圍,無需提交公司股東大會審議(上述測算數據未經審計,具體數據待交易完成後經公司審計機構予以審計確認)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.